ENTA new corporate slide set—updated for discontinuation of EDP-721 (HBV RNA destabilizer)—also new slide #19 with in vitro data on COVID protease inhibitor EDP-235: https://s22.q4cdn.com/306858242/files/doc_presentations/2021/11/Enanta-Corporate-Presentation-Final-11-18-21.pdf Note: The new slide #19 is different from #19 in the previous version of the slide set, which also coincidentally had new data on EDP-235.